The FDA has approved the antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd; Datroway) for adult patients with ...
Air pollution is one of the greatest environmental threats to human health. Every day, 99% of the global population breathes ...
Junshi Biosciences receives approval of toripalimab NDA from NMPA for first-line treatment of HER2 expressing urothelial carcinoma: Shanghai Saturday, May 23, 2026, 17:00 Hrs [IST ...
Key Points Interested in Exelixis, Inc.? Here are five stocks we like better. Exelixis is leaning on CABO growth in renal ...
Joy Milne, a British nurse, had an exceptionally sensitive sense of smell. She detected a different odor from her husband ...
Two-year and post-hoc SURPASS-ET analyses highlight the impact of treatment timing, with durable responses and improved progression-free survival supporting consideration of earlier ropeginterferon ...
BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) is characterized by impaired contractility and high ...